Posts tagged with "Pfizer Inc (NYSE:PFE)"

Stellar Set Of Numbers From Pfizer Inc. (NYSE:PFE)

Posted by admin January 29, 2014 0 Comment 1388 views

Pfizer Inc. (NYSE:PFE) recently reported a profit that was far ahead of analysts’ estimates. The company said that they had lowered the tax rate which was an industry high, and Pfizer’ effort will continue as it also has plans of repurchasing stocks in their billions.Pfizer Inc, the world’s largest drug maker, projected an effective rate of 27% […]

Why Pfizer Inc (NYSE:PFE) Was Forced To Reduce Its Operations In Puerto Rico?

Posted by Chris Bell November 26, 2013 0 Comment 3059 views

Companies are often forced to make tough choices and take hard decisions in order to maintain or improve their levels of profitability and ability to raise more revenue. Pfizer Inc (NYSE:PFE) is one such company, that intends to reduce its operations in Puerto Rico, by closing at least one of its manufacturing plants by 2017. […]

Will Amgen Inc. (NASDAQ:AMGN)’s Lipid Lowering Agent Get the USFDA Approval?

Posted by Nathan Alexander November 21, 2013 0 Comment 2435 views

Early this week, Amgen, Inc. (NASDAQ:AMGN) announced that an experimental drug evolocumab reduced LDL cholesterol levels in patients by over 50%. The company is scheduled to release results from this late stage trial by early 2014. The patients under the trial were receiving evolocumab once a month. The drug was also not associated with any […]

Pfizer Inc. (NYSE:PFE) Will Be Part Of Mission Therapeutics

Posted by Lacee Page November 19, 2013 0 Comment 1739 views

The $207 billion market capped Pfizer Inc. (NYSE:PFE) has been the latest big capped drug major which has part financed the latest round of funding sought by new and upcoming bio tech firm Mission Therapeutics. This U.K based development stage drug company announced yesterday that it has successfully completed the Series B round of funding […]

Another Jolt For BlackBerry Ltd (NASDAQ:BBRY) From Pfizer Inc. (NYSE:PFE)

Posted by George Brook November 17, 2013 0 Comment 2454 views

Struggling Canadian smartphone maker BlackBerry Ltd (NASDAQ:BBRY) has faced yet another major setback, as world’s largest pharmaceutical company Pfizer has decided to move away from Blackberry. Pfizer Inc. (NYSE:PFE), which has a large influence in the pharma industry, has asked its employees to move away from Blackberry phones to other devices such as iOS or […]

Pfizer Inc (NYSE:PFE) & Merck & Co Inc (NYSE:MRK) Miss The Bus

Posted by Lynn Eisler November 6, 2013 0 Comment 2320 views

Pfizer Inc (NYSE:PFE) continues its flat ride on bourses on Tuesday, though Dow Jones Industrial Average saw a robust rebound.  Both Pfizer Inc (NYSE:PFE) and Merck (NYSE:MRK) failed to take advantage of the rebound. Comparatively, Merck share prices fell further while Pfizer managed to maintain a steady, flat performance for the day. Pfizer is expectant […]

Three Active Pharma Stocks

Posted by Ryan Mandell November 5, 2013 0 Comment 1330 views

Our pick for the day for Pharma stocks includes PFE, MRK and BSX as each of these stocks saw movement at the browsers. Pfizer (NYSE:PFE) has posted gains of nearly 1.7% at the Dow today, following the release of the Institute for Supply Management‘s monthly Purchasing Manager’s Index. Along with PFE other major gainers at […]

What Does Pfizer Inc. (NYSE:PFE)’s Net Income Decline Mean?

Posted by Lynn Eisler October 30, 2013 0 Comment 1179 views

Pfizer Inc. (NYSE:PFE) released its 3Q13 earnings on October 29, 2013 with 19% decline in net income. The overall results remained better than expected, aided by stringent cost cutting measures and booming sales of cancer medicines approved over the past couple of years. World’s largest pharmaceutical company by revenues, ahead of Novartis AG (ADR) (NYSE:NVS) […]

Technical Milestones Achieved By Pfizer Inc. (NYSE:PFE)

Posted by Samantha Donahue October 25, 2013 0 Comment 2332 views

Yesterday, Pfizer Inc. (NYSE:PFE) announced about having achieved manufacturing related technical milestones as it would continue the development program for extended release of Remoxy capsules that contains therapeutic molecule oxycodone. The company received the guidance from the United States Food and Drug Administration (USFDA) earlier this year. Now Pfizer is working to proceed with the […]

Pfizer Inc. (NYSE:PFE) Continues To Press For Remoxy

Posted by Kristi Scott October 24, 2013 0 Comment 1507 views

Pfizer Inc. (NYSE:PFE) recorded steady performance, even as Dow Jones Industrial Average dropped its recent upward movement. Even as the Dow Jones remained in the red, large pharmaceuticals such as Merck & Co Inc. (NYSE:MRK) and Pfizer continued to remain strong. Pfizer nearly approached breakeven, even as Merck & Co Inc. (NYSE:MRK) posted 0.2% gains. […]